Hepatocellular Cancer Clinical Trials in Guangzhou, Guangdong
2 recruitingGuangzhou, Guangdong, China
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
Hepatocellular Cancer
AbbVie232 enrolled22 locationsNCT06858813
Recruiting
Phase 2
mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC
Stage III Hepatocellular Cancer (CNLC Staging)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University35 enrolled1 locationNCT05412589